Home » Newsletters » BioWorld Asia

BioWorld Asia

July 12, 2000

View Archived Issues

Arrow Completes #11M Round For Antimicrobial Programs

EU Patent Plan Would Reduce Costs, Encourage Innovation

Drug-Resistant HIV Strains Arise Prior To Start Of Drug Treatment

Ontario Invests In Three Centers, Plans To Become Biotech Hub

Brandys Steps Down At Genset; Director Assumes Top Positions

British Biotech Changes Focus, Seeks To Move Past Marimastat

Roche, Atugen Collaborate To Study Gene Function In Vivo

UK Genetics Commission Plans Open Discussion On Principles

Israeli Biotech Companies Continue Moving Forward

Australian Investors Launch Biotechnology Venture Fund

Lion Bioscience Seeks $191M In IPO On Nasdaq, Neuer Markt

Prodi Recognizes EU Need To Restore Confidence In Biotech

EPO Upholds CAT Patent On Phage Display Of Antibodies

NicOx Gets Positive Results In Early Dermatology Trial

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...